The technical challenges and election year posturing facing biotech ETFs belies what some believe is still a bullish long-term investment thesis. The improved outlook for the health care industry ...

IBB), the largest biotechnology exchange traded fund, is facing some critical technical resistance that could determine the ETF's near-term fate. After rallying late in the first quarter and to ...